Secondary Logo

Journal Logo

Persistent vasomotor symptoms and breast cancer in the Women's Health Initiative

Chlebowski, Rowan T.; Mortimer, Joanne E.; Crandall, Carolyn J.; More

Menopause. 26(6):578-587, June 2019.

Early life exposure to famine and reproductive aging among Chinese women

Wang, Nengying; Huang, Yinqiong; Wen, Junping; More

Menopause. 26(5):463-468, May 2019.

Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease

Karim, Roksana; Koc, Melissa; Rettberg, Jamaica R.; More

Menopause. 26(1):7-15, January 2019.

The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women

Moral, Eloy; Delgado, Juan L.; Carmona, Francisco; More

Menopause. 25(12):1418-1423, December 2018.

Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study

Waetjen, L. Elaine; Crawford, Sybil L.; Chang, Po-Yin; More

Menopause. 25(10):1094-1104, October 2018.

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

Prague, Julia K.; Roberts, Rachel E.; Comninos, Alexander N.; More

Menopause. 25(8):862-869, August 2018.

Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women

Cruz, Vera L.; Steiner, Marcelo L.; Pompei, Luciano M.; More

Menopause. 25(1):21-28, January 2018.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study

Crandall, Carolyn J.; Hovey, Kathleen M.; Andrews, Christopher A.; More

Menopause. 25(1):11-20, January 2018.

The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women

Harrington, Laura B.; Blondon, Marc; Cushman, Mary; More

Menopause. 24(4):360-370, April 2017.

Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study

Santoro, Nanette; Allshouse, Amanda; Neal-Perry, Genevieve; More

Menopause. 24(3):238-246, March 2017.

Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE)

Thurston, Rebecca C.; Johnson, B. Delia; Shufelt, Chrisandra L.; More

Menopause. 24(2):126-132, February 2017.

Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative

Drieling, Rebecca L.; LaCroix, Andrea Z.; Beresford, Shirley A.A.; More

Menopause. 23(11):1168-1175, November 2016.

Characterizing the trajectories of vasomotor symptoms across the menopausal transition

Tepper, Ping G.; Brooks, Maria M.; Randolph, John F. Jr; More

Menopause. 23(10):1067-1074, October 2016.

Sedentary lifestyle in middle-aged women is associated with severe menopausal symptoms and obesity

Blümel, Juan E.; Fica, Juan; Chedraui, Peter; More

Menopause. 23(5):488-493, May 2016.

The association between recent abuse and menopausal symptom bother: results from the Data Registry on Experiences of Aging, Menopause, and Sexuality (DREAMS)

Vegunta, Suneela; Kuhle, Carol; Kling, Juliana M.; More

Menopause. 23(5):494-498, May 2016.

Show: